| Literature DB >> 34356118 |
Husile Alatan1,2, Yinwei Chen1, Jinghua Zhou1, Li Wang1,3.
Abstract
Gastric adenocarcinoma (GAC) is the most frequent type of stomach cancer, characterized by high heterogeneity and phenotypic diversity. Although many novel strategies have been developed for treating GAC, recurrence and metastasis rates are still high. Therefore, it is necessary to screen new potential biomarkers correlated with prognosis and novel molecular targets. Gene expression profiles were obtained from the from NCBI Gene Expression Omnibus (GEO) database. We conduct an integrated analysis using the online Venny website to explore candidate hub genes between differentially expressed genes (DEGs) of two datasets. Gene ontology (GO) and Kyoto Encyclopedia 18 of Genes and Genomes (KEGG) pathway enrichment analysis found that extracellular matrix plays an important role in GAC. In addition, we applied protein-protein interaction (PPI) network analysis by using the Search Tool for the Retrieval of Interacting Genes (STRING) and visualized with Cytoscape software. Furthermore, we employed Cytoscape software to analyze the interactive relationship of candidate gene for further analysis. We found that ECM related proteins played an important role in GAC, and 15 hub genes were extracted from 123 DEGs genes. There were four hub genes (bgn, vcan, col1a1 and timp1) predicted to be associated with poor prognosis among the 15 hub genes.Entities:
Keywords: bioinformatics analysis; biomarkers; extracellular matrix; gastric adenocarcinoma
Mesh:
Substances:
Year: 2021 PMID: 34356118 PMCID: PMC8303807 DOI: 10.3390/genes12071104
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Volcano plot visualizing all the DEGs in GSE103236 and GSE9668. Red dots represent upregulated genes, green dots represent downregulated genes and gray dots represent genes without differential expression.
Screening of co-differentially expressed genes of GSE103236 and GSE96668 datasets.
| DEGs | List of Gene Symbols |
|---|---|
| Upregulated DEGs | ANXA2, APOC1, APOE, ASPM, ATAD2, AUNIP, BGN, BOP1, BYSL, C1orf112, CDH3, CEMIP, CENPF, CENPN, CENPW, CKAP2, CKS1B, CLDN1, CLDN7, COL1A1, COL5A2, CTHRC1, CTSV, DSCC1, ECT2, EIF6, ESM1, ETV4, EXO1, F12, FAM72D, FOXD2, GJB2, GTPBP4, HAVCR2, HJURP, HMGA1, IGF2BP3, KRT17, LEF1, LIPG, LRFN4, LRP8, MMP11, MMP3, MTHFD1L, MXRA5, MZT1, NEK2, NFE2L3, NOLC1, NPM3, PLAU, PMEPA1, PUS7, RIPK2, S100A10, S100A3, SEH1L, SERPINH1, SNX10, SOD2, SOX9, SPP1, SULF1, TEAD4, THBS2, THY1, TIMP1, TMEM158, TNFRSF12A, TPX2, UPP1, VCAN, ZFAS1 |
| Downregulated DEGs | ADHFE1, APLP1, APOBEC2, ARHGEF37, ATP4A, ATP4B, C16orf89, C2orf40, CCKBR, CD36, CHGA, CKB, CKMT2, DPT, ESRRG, FGA, FNDC5, FUT9, GAMT, GC, GCNT2, GHRL, GIF, GNG7, GPER1, GPX3, HDC, LIFR, MAL, METTL7A, MT1M, MYRIP, PDGFD, PLCXD3, PNPLA7, PPP2R3A, RCAN2, RERGL, RGN, RNASE1, RPRM, SIGLEC11, SLC25A4, SLC25A42, SLC2A12, SORBS2, SST, SYT4 |
Figure 2Venn diagram of all screened co-DEGs in GSE103236 and GSE9668. (A) Venn diagram of the upregulated co-DEGs. (B) Venn diagram of the down-regulated co-DEGs.
Figure 3GO functional annotation and KEGG pathway enrichment analysis of co-DEGs. (A) The top ten enriched BP of co-DEGs. (B) The top ten enriched CC of co-DEGs. (C) The top ten enriched MF of co-DEGs. (D) The KEGG pathway enrichment of co-DEGs.
GO terms functional enrichment analysis of codifferentially expressed genes.
| Category | Term | Count | |
|---|---|---|---|
| Biological Processes | GO:0007155~cell adhesion | 13 | 7.92 × 10−5 |
| GO:0008284~positive regulation of cell proliferation | 10 | 5.02 × 10−3 | |
| GO:0043066~negative regulation of apoptotic process | 8 | 3.84 × 10−2 | |
| GO:0070374~positive regulation of ERK1 and ERK2 cascade | 7 | 1.35 × 10−3 | |
| GO:0030335~positive regulation of cell migration | 7 | 1.75 × 10−3 | |
| GO:0030198~extracellular matrix organization | 7 | 2.40 × 10−3 | |
| GO:0007067~mitotic nuclear division | 7 | 7.52 × 10−3 | |
| GO:0008283~cell proliferation | 7 | 4.15 × 10−2 | |
| GO:0030199~collagen fibril organization | 6 | 6.88 × 10−6 | |
| GO:0006629~lipid metabolic process | 6 | 4.68 × 10−3 | |
| Molecular Function | GO:0005515~protein binding | 69 | 4.98 × 10−2 |
| GO:0005509~calcium ion binding | 14 | 1.01 × 10−3 | |
| GO:0003682~chromatin binding | 7 | 4.77 × 10−2 | |
| GO:0042393~histone binding | 5 | 9.13 × 10−3 | |
| GO:0005201~extracellular matrix structural constituent | 4 | 1.03 × 10−2 | |
| GO:0008900~hydrogen:potassium-exchanging ATPase activity | 2 | 1.99 × 10−2 | |
| GO:0030284~estrogen receptor activity | 2 | 3.30 × 10−2 | |
| GO:0071813~lipoprotein particle binding | 2 | 3.30 × 10−2 | |
| GO:0004111~creatine kinase activity | 2 | 3.95 × 10−2 | |
| GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity | 2 | 3.95 × 10−2 | |
| Cellular component | GO:0070062~extracellular exosome | 30 | 7.08 × 10−3 |
| GO:0005615~extracellular space | 27 | 4.46 × 10−7 | |
| GO:0005576~extracellular region | 27 | 1.20 × 10−5 | |
| GO:0048471~perinuclear region of cytoplasm | 12 | 2.49 × 10−3 | |
| GO:0005783~endoplasmic reticulum | 12 | 1.96 × 10−2 | |
| GO:0005730~nucleolus | 12 | 2.45 × 10−2 | |
| GO:0009986~cell surface | 10 | 9.16 × 10−3 | |
| GO:0031012~extracellular matrix | 9 | 7.28 × 10−4 | |
| GO:0005578~proteinaceous extracellular matrix | 8 | 1.90 × 10−3 | |
| GO:0045121~membrane raft | 7 | 2.34 × 10−3 | |
| GO:0005581~collagen trimer | 6 | 3.41 × 10−4 |
KEGG pathway enrichment analysis of codifferentially expressed genes.
| Category | Term | Count | |
|---|---|---|---|
| KEGG | hsa04971:Gastric acid secretion | 4 | 2.03 × 10−2 |
| hsa04512:ECM-receptor interaction | 5 | 4.98× 10−3 | |
| hsa04151:PI3K-Akt signaling pathway | 7 | 5.59 × 10−2 | |
| hsa00330:Arginine and proline metabolism | 3 | 6.02 × 10−2 | |
| hsa04510:Focal adhesion | 5 | 8.17 × 10−2 |
Figure 4The PPI network and the most important molecular module of co-DEGs. (A) The PPI network analyzed by the String tool and visualized by Cytoscape tool. (B,C) The two modules from the PPI network using the Cytoscape tool. Pink represents the up expression genes. Light blue is the down expression genes.
Figure 5The mRNA expression of 15 hub genes. Validation of the 15 hub genes in the GEPIA box plots showing those genes in mRNA expression using data from the TCGA database and GTEx data in GEPIA. * p-values < 0.01. (A) APOE; (B) ASPM; (C) ATAD2; (D) BGN; (E) CENPF; (F) CENPN; (G) COL1A1; (H) ECT2; (I) EXO1; (J) HJURP; (K) NEK2; (L) SPP1; (M) TIMP1; (N) TPX2; (O) VCAN.
Figure 6Survival analyses of six hub genes performed using the GEPIA website. Longrank p < 0.05 was considered to be statistically significant. (A) VCAN; (B) BGN; (C) COL1A1; (D) TIMP1.
Figure 7Correlation analyses of four hub genes performed using the GEPIA website. (A)The correlation between COL1A1 and BGN. (B) The correlation between VCAN and BGN. (C) The correlation between VCAN and COL1A1. (D) Table 1 and BGN. (E)The correlation between VCAN and TIMP1. (F) The correlation between COL1A1 and TIMP1.
Figure 8The immunohistochemistry (IHC) of BGN, VCAN, COL1A1 and TIMP1 between normal stomach tissue and cancerous stomach tissue in the human protein atlas. (A) The IHC of BGN in normal stomach tissue; (B) The IHC of BGN in cancerous stomach tissue; (C) The IHC of VCAN in normal stomach tissue; (D) The IHC of VCAN in cancerous stomach tissue; (E) The IHC of COL1A1 in normal stomach tissue; (F) The IHC of COL1A1 in cancerous stomach tissue; (G) The IHC of TIMP1 in normal stomach tissue; (H) The IHC of TIMP1 in cancerous stomach tissue.